Dr. Daniel Ostlie · Long-Term Sensory Function 3 years after Minimally Invasive Repair of Pectus Excavatum with Cryoablation
Follow
Article1 min read·Published Oct 2023Older

Long-Term Sensory Function 3 years after Minimally Invasive Repair of Pectus Excavatum with Cryoablation

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Oct 2023 · 1 min read

In brief

In brief

This prospective study evaluated long-term sensory outcomes in 47 patients (median age 18.4 years) three years after minimally invasive pectus excavatum repair with intercostal nerve cryoablation. Nearly half experienced mild chest wall hypoesthesia affecting less than 6% of treated surface area, while only 13% reported neuropathic symptoms requiring no treatment.

Written by the GCMD Library team from the article.

Daniel Ostlie

Introduction: Minimally invasive repair of pectus excavatum (MIRPE) with intercostal nerve cryoablation (Cryo) decreases length of hospitalization and opioid use, but long-term recovery of sensation has been poorly described. The purpose of this study was to quantify long-term hypoesthesia and neuropathic pain after MIRPE with Cryo. Methods: A prospective cohort study was conducted single-institution of patients ≤21 years who presented for bar removal. Consented patients underwent chest wall sensory testing and completed neuropathic pain screening. Chest wall hypoesthesia to cold, soft touch, and pinprick were measured as the percent of the treated anterior chest wall surface area (TACWSA); neuropathic pain was evaluated by questionnaire. Results: The study enrolled 47 patients; 87% male; median age 18.4 years. The median bar dwell time was 2.9 years. A median of 2 bars were placed; 80.9% were secured with pericostal sutures. At enrollment, 46.8% of patients had identifiable chest wall hypoesthesia. The mean percentage of TACWSA with hypoesthesia was 4.7 ± 9.3% (cold), 3.9 ± 7.7% (soft touch), and 5.9 ± 11.8% (pinprick). Hypoesthesia to cold was found in 0 dermatomes in 62%, 1 dermatome in 11%, 2 dermatomes in 17% and ≥3 dermatomes in 11%. T5 was the most common dermatome with hypoesthesia. Neuropathic symptoms were identified by 13% of patients; none required treatment. Conclusion: In long-term follow up after MIRPE with Cryo, 46.8% of patients experienced some chest wall hy

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →